Targeting hypoxia to improve non–small cell lung cancer outcome

A Salem, MC Asselin, B Reymen… - JNCI: Journal of the …, 2018 - academic.oup.com
Oxygen deprivation (hypoxia) in non–small cell lung cancer (NSCLC) is an important factor
in treatment resistance and poor survival. Hypoxia is an attractive therapeutic target …

Mechanism-based modeling of tumor growth and treatment response constrained by multiparametric imaging data

DA Hormuth, AM Jarrett, EABF Lima… - JCO clinical cancer …, 2019 - ascopubs.org
Multiparametric imaging is a critical tool in the noninvasive study and assessment of cancer.
Imaging methods have evolved over the past several decades to provide quantitative …

Overcoming hypoxia-restrained radiotherapy using an erythrocyte-inspired and glucose-activatable platform

H Huang, C Zhang, X Wang, J Shao, C Chen, H Li… - Nano Letters, 2020 - ACS Publications
Radiotherapy (RT) as one of the most powerful cancer treatment strategies has been greatly
restricted by tumor hypoxia. A mounting effort has been devoted to develop oxygen delivery …

18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to …

KM Reeves, PN Song, A Angermeier, DD Manna… - Clinical Cancer …, 2022 - AACR
Purpose: Hypoxia is a common characteristic of many tumor microenvironments, and it has
been shown to promote suppression of antitumor immunity. Despite strong biological …

Quantifying tumor heterogeneity via MRI habitats to characterize microenvironmental alterations in HER2+ breast cancer

AS Kazerouni, DA Hormuth, T Davis, MJ Bloom… - Cancers, 2022 - mdpi.com
Simple Summary Tumor heterogeneity influences tumor progression and response to
therapy, introducing a significant challenge in the treatment of breast cancer. We employed …

Multiparametric analysis of longitudinal quantitative MRI data to identify distinct tumor habitats in preclinical models of breast cancer

AK Syed, JG Whisenant, SL Barnes, AG Sorace… - Cancers, 2020 - mdpi.com
This study identifies physiological tumor habitats from quantitative magnetic resonance
imaging (MRI) data and evaluates their alterations in response to therapy. Two models of …

Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer

AM Jarrett, MJ Bloom, W Godfrey… - … and biology: a …, 2019 - academic.oup.com
The goal of this study is to develop an integrated, mathematical–experimental approach for
understanding the interactions between the immune system and the effects of trastuzumab …

Preclinical PET imaging of granzyme B shows promotion of immunological response following combination paclitaxel and immune checkpoint inhibition in triple …

TS Napier, CL Hunter, PN Song, BM Larimer… - Pharmaceutics, 2022 - mdpi.com
Advancements in monitoring and predicting of patient-specific response of triple negative
breast cancer (TNBC) to immunotherapy (IMT) with and without chemotherapy are needed …

Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses

Y Liu, Q Zhou, S Song, S Tang - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic reprogramming is not only an emerging hallmark of cancer, but also an essential
regulator of cancer cell adaptation to the microenvironment. Metabolic imaging targeting …

[HTML][HTML] Characterizing trastuzumab-induced alterations in intratumoral heterogeneity with quantitative imaging and immunohistochemistry in HER2+ breast cancer

AK Syed, R Woodall, JG Whisenant, TE Yankeelov… - Neoplasia, 2019 - Elsevier
The purpose of this study is to investigate imaging and histology-based measurements of
intratumoral heterogeneity to evaluate early treatment response to targeted therapy in a …